Literature DB >> 28039020

Protein kinases C as potential host targets for the inhibition of chikungunya virus replication.

Rana Abdelnabi1, Siti Naqiah Amrun2, Lisa F P Ng2, Pieter Leyssen1, Johan Neyts3, Leen Delang1.   

Abstract

We have shown previously that prostratin, a non-tumor promoting phorbol ester, inhibits chikungunya virus (CHIKV)-induced cytopathic effects in vitro. Prostratin is a potent activator of protein kinases C (PKC), a family of related serine/threonine kinases that regulate many cellular processes such as proliferation and apoptosis. The objective of this study was to explore the mechanism of the anti-CHIKV activity of prostratin. Prostratin reduced the production of infectious virus particles and viral protein accumulation in a dose-dependent manner at a post-entry step during virus replication. The antiviral effect of the compound was cell-dependent, with potent antiviral activity observed in human skin fibroblasts cells, the primary target cells of CHIKV infection. The antiviral activity of prostratin was markedly reduced in the presence of PKC inhibitors, therefore confirming that the antiviral effect results from an activation of PKCs. Together these results showed that PKCs are potential host targets for the inhibition of CHIKV replication.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chikungunya virus; Prostratin; Protein kinase C; Rottlerin; Sotrastaurin

Mesh:

Substances:

Year:  2016        PMID: 28039020     DOI: 10.1016/j.antiviral.2016.12.020

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  9 in total

1.  Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.

Authors:  Rana Abdelnabi; Kristina Kovacikova; Johan Neyts; Leen Delang; Julia Moesslacher; Kim Donckers; Verena Battisti; Pieter Leyssen; Thierry Langer; Gerhard Puerstinger; Gilles Quérat; Changqing Li; Etienne Decroly; Ali Tas; Arnaud Marchand; Patrick Chaltin; Bruno Coutard; Martijn van Hemert
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 2.  Vaccine and Therapeutic Options To Control Chikungunya Virus.

Authors:  Ann M Powers
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

3.  Adenosine restrains ILC2-driven allergic airway inflammation via A2A receptor.

Authors:  Qiang Xiao; Xu Han; Gaoyu Liu; Dongmei Zhou; Lijuan Zhang; Juan He; Haixu Xu; Pan Zhou; Quan Yang; Jiangfan Chen; Jie Zhou; Guanmin Jiang; Zhi Yao
Journal:  Mucosal Immunol       Date:  2021-12-17       Impact factor: 7.313

4.  Rottlerin plays an antiviral role at early and late steps of Zika virus infection.

Authors:  Shili Zhou; Quanshi Lin; Changbai Huang; Xiaotong Luo; Xu Tian; Chao Liu; Ping Zhang
Journal:  Virol Sin       Date:  2022-08-05       Impact factor: 6.947

5.  MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro, In Vivo, and Ex Vivo.

Authors:  Soumyajit Ghosh; Supriya Suman Keshry; Bharat Bhusan Subudhi; Soma Chattopadhyay; Saikat De; Chandan Mahish; Chinmayee Mohapatra; Ankeeta Guru; Prabhudutta Mamidi; Ankita Datey; Sweta Smita Pani; Dileep Vasudevan; Tushar Kant Beuria; Subhasis Chattopadhyay
Journal:  Antimicrob Agents Chemother       Date:  2022-06-29       Impact factor: 5.938

Review 6.  Prophylactic strategies to control chikungunya virus infection.

Authors:  Friederike I L Hucke; Malena Bestehorn-Willmann; Joachim J Bugert
Journal:  Virus Genes       Date:  2021-02-15       Impact factor: 2.332

Review 7.  The medicinal chemistry of Chikungunya virus.

Authors:  Edeildo F da Silva-Júnior; Giovanni O Leoncini; Érica E S Rodrigues; Thiago M Aquino; João X Araújo-Júnior
Journal:  Bioorg Med Chem       Date:  2017-06-29       Impact factor: 3.641

Review 8.  Current and Promising Antivirals Against Chikungunya Virus.

Authors:  Friederike I L Hucke; Joachim J Bugert
Journal:  Front Public Health       Date:  2020-12-15

Review 9.  Antivirals against the Chikungunya Virus.

Authors:  Verena Battisti; Ernst Urban; Thierry Langer
Journal:  Viruses       Date:  2021-07-05       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.